Navigation Links
Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
Date:9/10/2008

Mega-dose Resveratrol, Sirtuin1 gene Target Discredited; Lower Dose, Array

of Small Molecules (Longevinex(R)) Exert Greater Effect

SAN DIMAS, Calif., Sept. 10 /PRNewswire/ -- While the red wine molecule resveratrol (rez-vair-ah-trawl) has recently attracted scientific and public attention as a longevity molecule that allegedly mimics the effects of a calorie-restricted diet, the science surrounding this molecule has taken a dramatic turn in recent months, according to Bill Sardi, spokesperson for Longevinex(R) (long-jev-in-ex), a major brand resveratrol supplement.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU004)

Published research studies now show:

-- Mice fed high-dose resveratrol did not live as long as mice fed a plain standard calorie diet. Animals on the lower dose (360 milligram human equivalent) lived longer than those on the higher dose (1565 mg) of resveratrol. [Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span. Cell Metabolism 2008 Aug;8(2):157-68]

-- The Sirtuin1 gene, once called the "holy grail" of longevity and believed to be the gene target of calorie restriction, has not been found to be universally activated by a limited calorie diet. A calorie-restricted diet results in more Sirtuin1 gene-derived proteins by exerting stabilization effects, not by activation of the gene. This new finding throws a scientific cloud over the use of Sirtuin1 gene activation tests as a measure of resveratrol activity. [Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008 Jul 1; 22(13):1753-7; Regulation of SIRT1 protein levels by nutrient availability. FEBS Letters. 2008 Jul 9; 582(16):2417-23]

-- While researchers once advised consumers to wait for stronger synthetic molecules that can stimulate the Sirtuin1 gene by 1
'/>"/>

SOURCE Resveratrol Partners, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
2. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
3. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
4. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
5. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
6. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
7. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
8. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
9. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
10. Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
11. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).../ -- Volcano Corporation (Nasdaq: VOLC ), a leade...ducts for the diagnosis and treatment of coronary ...will be participating in the Third Annual Canaccor...0. ,, The presentation by Scott Huennekens, pre...1 p.m., Pacific Standard Time (4 p.m., Eastern Sta...
(Date:11/9/2009)...tCall/ -- Cardiac Science Corporation (Nasdaq:...fibrillator ( AED ) and diagnostic cardiac monit...llion for the third quarter ended September 30, 20...y also recorded a charge of $18.5 million for an A...44.0 million to increase its valuation allowance a...
(Date:11/9/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...8th annual Global Congress for Minimally Invasive ...in Orlando, Florida. Results from two clinical st...ology/Gynecology products, including pelvic floor ...ems used to treat pelvic floor vaginal wall prolap...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5New research 3A Consumption of sugar substitutes assists in long term weight control 55125 1New research 3A Consumption of sugar substitutes assists in long term weight control 55125 2When cells run out of fuel 9677 1When cells run out of fuel 9677 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 1Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 3
...07 - Hemispherx Biopharma,Inc. (AMEX: HEB) announ...l of Immunology, April 2007) that explains the uni...rimental therapeutic,Ampligen(R) (Poly I : Poly C...notherapy for Chronic Fatigue Syndrome and as an,a...-reviewed study shows conclusively that the biolog...
...frontera AG announced,that an interim report regar...eratosis was received today from an independent re... investigate the,efficacy and safety of several do...ments received today refer to the clinical results... about the results,after twelve weeks will follow....
Other Medicine Technology:New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
(Date:11/9/2009)... Businesses of all sizes lookin...for the H1N1 pandemic have a new resource at their... (PRWEB) November 9, 2009 -- Human resource (HR) p...d response efforts for the H1N1 pandemic have a ne...nnesota’s Center for Infectious Disease Rese...
(Date:11/9/2009)... House Delivers on Election Promise. Now Is Time f...wire-USNewswire/ -- The following is a statement b...enerations of struggle and decades of delay, the U...t -- and, to pass historic reform legislation to a... access to high quality, affordable health care. T...
(Date:11/9/2009)...RIVERWOODS, Ill., Nov. 9 The House...ealth Care for America Act , which passed by a vot...tes several significant changes to the tax code an...ely to appear in any Senate version, requiring ext...H has issued a Special Tax Briefing on the tax...
(Date:11/9/2009)...WASHINGTON, Nov. 9 The Churchill...s Award For Leadership to J.W. "Bill" Marriott for...rough progressive free market practices and foster...e. Mr. Marriott will receive his award at a ceremo...ngton D.C. Four Seasons Hotel. ,, "This is a t...
(Date:11/9/2009)...in mice reports success with drugs that inhibit es...ews) -- Two drugs used to treat breast cancer and ...ccording to a new study. , The drugs also clear...and prevented the onset of cancer in mice with pre...vestrant and the breast cancer/osteoporosis drug r...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
... disease that can have Complication as its other n...could have, the dreaded would be the foot ulcer, a...n. For diabetics with this dreaded foot ulcer, ... healing of foot ulcers. People with diabetes m...
...are being developed on a daily basis. One of these...nt of those suffering from a degenerative eye cond...sels to grow underneath the retina and leak fluid,...of damaging the retinal tissue. This is a two-s...
...l companies hope to strike a pot of gold by making... war that is likely to escalate in coming days. ...panies to develop anti-AIDS drugs and market it in... entry of four more pharmaceutical companies inclu...
...ing the worst forms of nightmare over the past 3 w... but the threat of malaria . Malaria , not a ... tribal areas of Munger, 200 km (125 miles) southe...id the state's health minister Mr.Shakuni Choudhar...
... the recent issue of the American Journal of Epide...elp protect against a hip fracture. According to D...al, Glostrup, Denmark, and colleagues, when people... hip fractures. In the study, they found tha...
...ministration (FDA) at a conference in Washington, ...ts kind that directly removes the sign of a protei...eatment for chronic myelogenous leukemia (CML). ...rectly cause the disease. Gleevec, was discover...
Other Medicine News:
Nova Epi-fluorescence
...are the hallmark of these stereozoom fluorescent m...n mind. The top (incident) circular 9W fluorescent...inating shadows while remaining cool to the touch....e with 10x to 44x zoom magnification or high-power...
...vative and efficient inverted routine microscope. ...cility. Improved mechanics and increased stability...cular and TS100-F trinocular models. The TS100-F t...ts Nikon's FX-III series photomicrographic systems...
...system utilizes an evanescent wave to excite singl...e coverglass. Extendable "stratum structure". This...th TIRF and epi-fluorescence illumination systems,...ies. It also allows their dedicated filters to be ...
Medicine Products: